You are viewing the site in preview mode

Skip to main content

Advertisement

Table 3 Consumption on classes of antibacterial & anti-fungal chemotherapeutic agents

From: Antimicrobial consumption, costs and resistance patterns: a two year prospective study in a Romanian intensive care unit

Class DDD / 1000 PATIENT-DAYS
Total S I S II S III S IV
Cephalosporins 264.19 87.75 37.63 133.68 5.13
 I-st generation 0 0 0 0 0
 II-nd generation 46.96 27.35 4.98 14.50 0.13
 III-rd generation 198.19 57.74 31.97 103.54 4.93
 IV-th generation 13.43 1.51 0 11.92 0
 V-th generation 5.60 1.15 0.67 3.72 0.06
Carbapenems 244.59 8.16 53.84 160.36 22.23
Glycopeptides 132.94 6.13 20.23 96.97 9.61
Polymyxins 115.47 1.15 3.03 103.02 8.27
Penicillins 109.61 20.46 13.47 73.30 2.38
Fluoroquinolones 93.72 13.48 22.42 51.95 5.87
Anti-fungal drugs 92.02 0.91 13.29 68.98 8.84
Imidazole derivatives 27.54 4.67 4.93 16.74 1.20
Aminoglycosides 26.55 4.29 3.22 17.63 1.41
Lincosamides 19.68 6.34 2.75 10.53 0.06
Glycylcyclines 15.67 0 4.68 8.81 2.18
Antimycobacterials 9.74 0 0 0 9.74
Oxazolidinones 8.49 0.64 0.32 7.53 0
Sulfonamides 7.16 0 4.54 2.31 0.31
Macrolides 2.18 0.26 0 1.92 0
Aminophenols 1.52 0 0 1.52 0
Tetracyclines 0.90 0 0 0.90 0
Monobactams 0.43 0 0 0.43 0
TOTAL antibacterial treatments 1080.38 153.33 171.06 687.6 68.39
TOTAL antibacterial & anti-fungal treatments 1172.40 154.24 184.35 756.58 77.23